Search

Christopher R. Stone

Examiner (ID: 15088, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1628, 4173, 1614
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18244422 [patent_doc_number] => 20230076733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => Combination Therapy [patent_app_type] => utility [patent_app_number] => 17/791571 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791571 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/791571
Combination Therapy Jan 7, 2021 Pending
Array ( [id] => 16930823 [patent_doc_number] => 20210196712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => METHODS OF TREATING COCHLEAR SYNAPTOPATHY [patent_app_type] => utility [patent_app_number] => 17/142742 [patent_app_country] => US [patent_app_date] => 2021-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/142742
METHODS OF TREATING COCHLEAR SYNAPTOPATHY Jan 5, 2021 Abandoned
Array ( [id] => 16898885 [patent_doc_number] => 20210177801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS [patent_app_type] => utility [patent_app_number] => 17/129678 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129678 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129678
UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS Dec 20, 2020 Abandoned
Array ( [id] => 20438622 [patent_doc_number] => 12509449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-30 [patent_title] => Anthelmintic compounds comprising a quinoline structure [patent_app_type] => utility [patent_app_number] => 17/785656 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49378 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/785656
Anthelmintic compounds comprising a quinoline structure Dec 16, 2020 Issued
Array ( [id] => 17602830 [patent_doc_number] => 11331299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Medicinal use of serrulatane diterpenes [patent_app_type] => utility [patent_app_number] => 17/123539 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 49407 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123539 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/123539
Medicinal use of serrulatane diterpenes Dec 15, 2020 Issued
Array ( [id] => 17602830 [patent_doc_number] => 11331299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Medicinal use of serrulatane diterpenes [patent_app_type] => utility [patent_app_number] => 17/123539 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 49407 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123539 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/123539
Medicinal use of serrulatane diterpenes Dec 15, 2020 Issued
Array ( [id] => 16868851 [patent_doc_number] => 20210162318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => SYSTEM FOR FILTERING ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/122564 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/122564
System for filtering organic compounds Dec 14, 2020 Issued
Array ( [id] => 19550931 [patent_doc_number] => 12134627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-05 [patent_title] => Boron hydroxyl-containing organic compound, method for preparing same and use thereof [patent_app_type] => utility [patent_app_number] => 17/607409 [patent_app_country] => US [patent_app_date] => 2020-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7547 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/607409
Boron hydroxyl-containing organic compound, method for preparing same and use thereof Dec 13, 2020 Issued
Array ( [id] => 18222909 [patent_doc_number] => 20230061903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => ENHANCED PRODUCTION OF HUMIC ACIDS FROM COAL-LIGNITE VIA WATER-OXYGEN SYSTEMS [patent_app_type] => utility [patent_app_number] => 17/783578 [patent_app_country] => US [patent_app_date] => 2020-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783578 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/783578
Enhanced production of humic acids from coal-lignite via water-oxygen systems Dec 9, 2020 Issued
Array ( [id] => 19584916 [patent_doc_number] => 20240382473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => Combination Therapies for Treatment of Myelodysplastic Syndrome [patent_app_type] => utility [patent_app_number] => 17/782033 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782033 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782033
Combination Therapies for Treatment of Myelodysplastic Syndrome Dec 3, 2020 Abandoned
Array ( [id] => 16718522 [patent_doc_number] => 20210085669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE 1 (IDH-1) MUTATION [patent_app_type] => utility [patent_app_number] => 17/112269 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112269 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112269
Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation Dec 3, 2020 Issued
Array ( [id] => 18167976 [patent_doc_number] => 20230034584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => INHIBITORS OF SHP2 [patent_app_type] => utility [patent_app_number] => 17/782360 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782360 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782360
INHIBITORS OF SHP2 Dec 2, 2020 Abandoned
Array ( [id] => 18294204 [patent_doc_number] => 20230103890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => Photooxygenation Catalyst Compound and Medicine Comprising Same [patent_app_type] => utility [patent_app_number] => 17/780720 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780720 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/780720
Photooxygenation Catalyst Compound and Medicine Comprising Same Dec 1, 2020 Pending
Array ( [id] => 19411706 [patent_doc_number] => 12077511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Organic amine salt of key intermediate of Elagolix sodium and preparation method thereof [patent_app_type] => utility [patent_app_number] => 17/426522 [patent_app_country] => US [patent_app_date] => 2020-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1001 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426522 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426522
Organic amine salt of key intermediate of Elagolix sodium and preparation method thereof Nov 23, 2020 Issued
Array ( [id] => 17170285 [patent_doc_number] => 20210323955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => METHODS AND AGENTS FOR TREATING DISEASE [patent_app_type] => utility [patent_app_number] => 17/101753 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101753 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101753
Methods and agents for treating disease Nov 22, 2020 Issued
Array ( [id] => 17065723 [patent_doc_number] => 20210267938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/952401 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51474 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952401
MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF Nov 18, 2020 Abandoned
Array ( [id] => 18147585 [patent_doc_number] => 20230021442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => PHENOTHIAZINE FERROPTOSIS INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/778831 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778831 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778831
Phenothiazine ferroptosis inhibitor, preparation method therefor and application thereof Nov 17, 2020 Issued
Array ( [id] => 17571059 [patent_doc_number] => 11319317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => (Hetero)arylamide compound for inhibiting protein kinase activity [patent_app_type] => utility [patent_app_number] => 17/098675 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15562 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098675
(Hetero)arylamide compound for inhibiting protein kinase activity Nov 15, 2020 Issued
Array ( [id] => 16838329 [patent_doc_number] => 20210146341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => SUPPORTED COPPER CATALYST AND SELECTIVE HYDROGENATION OF FURAN-BASED COMPOUNDS USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/096835 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9769 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096835 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/096835
Supported copper catalyst and selective hydrogenation of furan-based compounds using the same Nov 11, 2020 Issued
Array ( [id] => 18207442 [patent_doc_number] => 20230053699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/774814 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774814 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/774814
Substituted-isoxazoline-containing aromatic compound, preparation method therefor, herbicidal composition and use thereof Nov 3, 2020 Issued
Menu